 |
 |
|
|
RESÚMENES FEBRERO 2008 |
Schizophrenia-Psychotic Disorders & Antipsychotics
(Haga un click en la información del journal para acceder al resúmen)
5 – doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3 –
revisión, abierto, básico; 2 – casos; 1 – opinión
GRATIS = Texto gratuito en algunos
países de la región iberoamericana (algunos artículos requieren ir a la tabla
de contenidos del número actual de la revista)
3 - Insight and treatment attitude
in schizophrenia: comparison of patients on depot and atypical antipsychotics
P. N.
Mahadun, M. Marshall
Psychiatric Bulletin
(2008) 32: 53-56
3 - Adjunct extended-release valproate semisodium in late life
schizophrenia
Martha Sajatovic, Nicoleta Coconcea, Rosalinda V.
Ignacio, Frederic C. Blow, Robert W. Hays, Kristin A. Cassidy, William J. Meyer
International Journal of Geriatric Psychiatry. Volume 23, Issue 2, Pages 142 - 147
3 - Correlations of attitudes toward antipsychotic drugs with insight and
objective psychopathology in schizophrenia
Paola
Rocca, Barbara Crivelli, Federica Marino, Tullia Mongini,
Francesca Portaleone and Filippo Bogetto
Comprehensive Psychiatry. Volume 49, Issue 2, March-April 2008, Pages 170-176
3 - Antipsychotics differ in their ability to internalise human dopamine D2S
and human serotonin 5-HT1A receptors in HEK293 cells
Peter
Heusler, Adrian Newman-Tancredi,
Timothé Loock and Didier Cussac
European Journal of Pharmacology. Volume 581, Issues 1-2, 26 February 2008, Pages 37-46
3 - Antipsychotics increase vesicular glutamate transporter 2 (VGLUT2) expression in thalamolimbic pathways
Larissa
Moutsimilli, Severine
Farley, Marie-Anne El Khoury, Christophe Chamot, Jean-Baptiste Sibarita, Victor
Racine, Salah El Mestikawy,
Flavie Mathieu, Sylvie
Dumas, Bruno Giros and Eleni
T. Tzavara
Neuropharmacology. Volume 54, Issue 3, March 2008, Pages 497-508
3 - Bexarotene
as Add-On to Antipsychotic Treatment in Schizophrenia Patients: A Pilot
Open-Label Trial
Lerner,
Vladimir; Miodownik, Chanoch;
Gibel, Anatoly; Kovalyonok,
Ekateryna; Shleifer,
Tatyana; Goodman, Ann B; Ritsner, Michael S
Clinical
Neuropharmacology. 31(1):25-33, January/February
2008
2 - First Administration of Cytidine Diphosphocholine and Galantamine in Schizophrenia: A Sustained [alpha]7 Nicotinic Agonist Strategy
Deutsch,
Stephen I; Schwartz, Barbara L; Schooler, Nina R; Rosse, Richard B; Mastropaolo,
John; Gaskins, Brooke
Clinical
Neuropharmacology. 31(1):34-39, January/February
2008
GRATIS 3 - Pharmacological Treatment of Cognition in
Schizophrenia: An Idea Whose Method Has Come
Philip D. Harvey, and Barbara A. Cornblatt
Am J Psychiatry
165:163-165, February 2008
5 -
Metformin Addition Attenuates Olanzapine-Induced
Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: A Double-Blind,
Placebo-Controlled Study
Ren-Rong Wu, Jing-Ping
Zhao, Xiao-Feng Guo, Yi-Qun He, Mao-Sheng Fang, Wen-Bin Guo, Jin-Dong Chen, and
Le-Hua Li
Am J Psychiatry Published
February 1, 2008
3! - Add-On Mirtazapine Enhances Effects on Cognition
in Schizophrenic Patients Under Stabilized Treatment
With Clozapine
Roberto
Delle Chiaie, Massimo Salviati, Samantha Fiorentini and Massimo Biondi
Experimental and Clinical Psychopharmacology. Volume 15, Issue 6, December 2007, Pages 563-568
3< - Aripiprazole: Effectiveness and Safety Under Naturalistic Conditions
Rosaria
Di Lorenzo, Alessandra Amoretti, Matilde Forghieri, Fiorenza Fiorini, Susanna
Genedani and Marco Rigatelli
Experimental and Clinical Psychopharmacology. Volume 15, Issue 6, December 2007, Pages 569-575
3! - Higher Risk of Offspring
Schizophrenia Following Antenatal Maternal Exposure to Severe Adverse Life
Events
Ali S. Khashan,
Kathryn M. Abel, Roseanne McNamee, Marianne G. Pedersen, Roger T. Webb, Philip
N. Baker, Louise C. Kenny, Preben Bo Mortensen
Arch Gen Psychiatry. 2008;65(2):146-152
3! - Longitudinal Progression of
Movement Abnormalities in Relation to Psychotic Symptoms in Adolescents at High
Risk of Schizophrenia
Vijay A. Mittal,
Craig Neumann, Mary Saczawa; Elaine F. Walker
Arch Gen Psychiatry. 2008;65(2):165-171
3 - Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone
(RIS) in rats
Jing
Zuo, Zhening Liu, Xuan Ouyang, Haihong
Liu, Yihui Hao, Lin Xu and Xiao-Hong Lu
3 - Oral risperidone, olanzapine
and quetiapine versus haloperidol in psychotic
agitation
Vincenzo
Villari, Paola Rocca, Valeria Fonzo, Cristiana Montemagni, Pasquale Pandullo
and Filippo Bogetto
3! - Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the
activity of its metabolite, allopregnanolone, a
positive GABAA modulating neurosteroid
Mahendra Bishnoi, Kanwaljit Chopra and Shrinivas K. Kulkarni
3 - Antipsychotic drug administration differentially affects [3H]muscimol and [3H]flunitrazepam GABAA receptor binding sites
Kelly
J. Skilbeck, Jennifer N. O'Reilly, Graham A.R.
Johnston and Tina Hinton
4< - Botulinum toxin in the treatment of orofacial tardive dyskinesia: A single blind study
Christina
W. Slotema, Peter N. van Harten, Richard Bruggeman and Hans W. Hoek
3 - Long-term perospirone treatment with a single
dose at bedtime in schizophrenia: Relevant to intermittent dopamine D2
receptor antagonism
Ichiro
Kusumi, Takuya Masui and Tsukasa Koyama
3 - Treatment with haloperidol and diazepam alters GABAA receptor
density in the rat brain
Mark
C. McLeod, Suresh Sundram and Brian Dean
3 -
New generation antipsychotic drugs and compliance behaviour
Voruganti, Lakshmi P; Baker, Laura
K; Awad, A George
Current Opinion in Psychiatry. 21(2):133-139, March 2008
3 -
The effect of cannabis on the brain: can it cause brain anomalies that lead to
increased risk for schizophrenia?
DeLisi, Lynn E
Current Opinion in
Psychiatry. 21(2):140-150, March 2008
5! - Tardive dyskinesia and new
antipsychotics
Correll, Christoph U; Schenk,
Eva
Current Opinion in Psychiatry. 21(2):151-156, March 2008
3 -
Predictors of long-term outcome in schizophrenia
Emsley, Robin; Chiliza, Bonginkosi; Schoeman, Renata
Current Opinion in Psychiatry. 21(2):173-177, March 2008
3 -
Genes and structural brain imaging in schizophrenia
van Haren, Neeltje E; Bakker, Steven C; Kahn, Rene
S
Current Opinion in Psychiatry. 21(2):161-167, March 2008
3! - Major Changes in Glucose Metabolism, Including
New-Onset Diabetes, Within 3 Months After Initiation of or Switch to Atypical
Antipsychotic Medication in Patients With Schizophrenia and Schizoaffective
Disorder
Ruud van Winkel,
Marc De Hert, Martien Wampers, Dominique Van Eyck, Linda Hanssens,
Andre Scheen, and Joseph Peuskens
J Clin Psychiatry February
6, 2008: e1-e8
3 - Social-psychiatric and
Ethical Reflections About Prevention of Schizophrenic Disorders
W. Machleidt, B. R. Brüggemann
Fortschr Neurol Psychiatr 2008; 76: 97-104
3 - Chronic haloperidol and clozapine produce different patterns of effects on
phosphodiesterase-1B, -4B, and -10A expression in rat striatum
Daniel
Dlaboga, Hassan Hajjhussein
and James M. O'Donnell
Neuropharmacology. Volume 54, Issue 4, March 2008, Pages 745-754
3! - Course of cognitive functioning during the stabilization phase of
schizophrenia
Stefan
Klingberg, Andreas Wittorf,
Stephanie Sickinger, Gerhard Buchkremer
and Georg Wiedemann
Journal of Psychiatric Research. Volume 42, Issue 4, March 2008, Pages 259-267
5 - Effects of haloperidol and risperidone on cerebrohemodynamics in drug-naive schizophrenic patients
Shin-Min
Lee, Yuan-Hwa Chou, Min-Hui
Li, Fang-Jung Wan and Mao-Hsiung Yen
Journal of Psychiatric Research. Volume 42, Issue 4, March 2008, Pages 328-335
3 - Pharmacodynamic
consequences of P-glycoprotein-dependent pharmacokinetics of risperidone and haloperidol in mice
Katrin M. Kirschbaum, Stefanie Henken, Christoph Hiemke and Ulrich
Schmitt
Behavioural Brain
Research.
Volume 188, Issue 2, 9 April 2008, Pages 298-303
3 - Chronic treatment with aripiprazole induces differential gene expression in the
rat frontal cortex
Min-Chih
Cheng, Ding-Lieh Liao, Chao A. Hsiung,
Chih-Yu Chen, Yu-Chieh Liao
and Chia-Hsiang Chen
The
International Journal of Neuropsychopharmacology
(2008), 11:207-216
GRATIS (require suscripción) 3! - Relationship between obesity and antipsychotic drug use in the adult
population: A longitudinal, retrospective claim database study in Primary Care
settings
Antoni Sicras-Mainar,
Ruth Navarro-Artieda, Javier Rejas-Gutiérrez,
Milagrosa Blanca-Tamayo
Neuropsychiatric Disease and Treatment. On-Line Early. February 2008
5 -
Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine
fumarate in stable outpatients with schizophrenia
Moller, Hans-Jurgen; Johnson,
Sunny; Mateva, Temenuzhka; Brecher, Martin; Svensson, Ola;
Miller, Frank; Meulien, Didier; on behalf of the
Study 146 investigators
International
Clinical Psychopharmacology. 23(2):95-105, March 2008
3! - Antipsychotic-Induced Hyperprolactinemia
Inhibits the Hypothalamo-Pituitary-Gonadal Axis and
Reduces Bone Mineral Density in Male Patients With Schizophrenia
Taishiro Kishimoto,
Koichiro Watanabe, Naoki Shimada, Kazuya Makita, Gohei Yagi, and Haruo Kashima
J Clin Psychiatry February
13, 2008: e1-e7
5< - Modafinil: A Candidate for
Pharmacotherapy of Negative Symptoms in Schizophrenia
John H. Peloian and Joseph M. Pierre
Progress
in Neurotherapeutics and Neuropsychopharmacology
(2008), 3: 259-274
3 - New Approaches to Treatment
of Schizophrenia by Enhancing N-methyl-D-aspartate Neurotransmission
Guochuan Emil
Tsai
Progress
in Neurotherapeutics and Neuropsychopharmacology
(2008), 3: 275-289
3 - Paliperidone-ER:
first atypical antipsychotic with oral extended release formulation
Marion
Lautenschlager and Andreas Heinz
Expert Review of Neurotherapeutics. February 2008, Vol. 8, No. 2, Pages 193-200
GRATIS 3 - The Schizophrenia Outpatient Health Outcomes (SOHO)
study: 3-year results of antipsychotic treatment discontinuation and related
clinical factors in
Antonio Ciudad, Josep María
Haro, Jordi Alonso, Manuel Bousoño, David Suárez, Diego Novick and Inmaculada Gilaberte
European
Psychiatry. Volume 23, Issue 1, January 2008, Pages 1-7
3 - Deficits
of Social-Cognitive and Social-Perceptual Aspects of Theory of Mind in Remitted
Patients With Schizophrenia: Effect of Residual
Symptoms
Bora, Emre; Gokcen, Sezen; Kayahan, Bulent; Veznedaroglu, Baybars
Journal of Nervous & Mental Disease.
196(2):95-99, February 2008
3! -
Excessive Brain
Volume Loss Over Time in Cannabis-Using First-Episode
Schizophrenia Patients
Monica Rais,
Wiepke Cahn, Neeltje Van Haren, Hugo Schnack, Esther Caspers, Hilleke Hulshoff Pol, and René Kahn
Am J Psychiatry Published
February 15, 2008
5! -
Atomoxetine and Osmotically Released
Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder:
Acute Comparison and Differential Response
Jeffrey H. Newcorn,
Christopher J. Kratochvil, Albert J. Allen, Charles
D. Casat, Dustin D. Ruff, Rodney J. Moore, David
Michelson, and Atomoxetine/Methylphenidate
Comparative Study Group
Am J Psychiatry Published
February 15, 2008
GRATIS 3! - Atypical
antipsychotic medication poisoning: an evidence-based consensus guideline for
out-of-hospital management
Cobaugh DJ, Erdman AR,
Booze LL, Scharman EJ, Christianson G, Manoguerra AS, Caravati EM, Chyka PA, Woolf AD, Nelson LS, Troutman WG
Clin Toxicol
(Phila) 2007 Dec;45(8):918-42
GRATIS (require registro) 3! - Serum substance P levels in patients with chronic schizophrenia treated
with typical or atypical antipsychotics
Takahiko Nagamine
Neuropsychiatric Disease and Treatment. On-Line Early. February 2008
5 - Efficacy of selegiline
add on therapy to risperidone in the treatment of the
negative symptoms of schizophrenia: a double-blind randomized
placebo-controlled study
Afshar Amiri,
Ahmad-Ali Noorbala, Ali-Akbar Nejatisafa,
Abolfazl Ghoreishi,
Mohammad-Kamran Derakhshan,
Mohammad-Reza Khodaie-Ardakani, Mohammad Hajiazim, Maedeh Raznahan, Shahin Akhondzadeh
Human
Psychopharmacology: Clinical and Experimental. Volume 23, Issue 2, Pages 79 - 86
3! - S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a Preferential Dopamine D3 versus D2
Receptor Antagonist and Potential Antipsychotic Agent: III. Actions in Models of
Therapeutic Activity and Induction of Side Effects
Mark J.
Millan, Florence Loiseau,
Anne Dekeyne, Alain Gobert,
Gunnar Flik, Thomas I. Cremers,
Jean-Michel Rivet, Dorothée Sicard,
Rodolphe Billiras, and Mauricette Brocco
3 -
Catatonic Syndrome: Importance of Detection and Treatment with Lorazepam
R. Seethalakshmi; S. Dhavale; Kalpana Suggu; Mantosh Dewan
Annals of Clinical
Psychiatry, Volume 20, Issue 1 February 2008, pages 5 - 8
3! -
Patterns of Quetiapine Use in Psychiatric Inpatients:
An Examination of Off-Label Use
Noah S. Philip;
Kerry Mello; Linda L. Carpenter; Audrey R. Tyrka;
Annals of Clinical
Psychiatry, Volume 20, Issue 1 February 2008, pages 15 - 20
3 -
Antipsychotics, Glycemic Disorders, and
Life-Threatening Diabetic Events: A Bayesian Data-Mining Analysis of the FDA
Adverse Event Reporting System (1968-2004)
William DuMouchel;
David Fram; Xionghu
Yang; Ramy A. Mahmoud;
Amy L. Grogg; Luella Engelhart;
Krishnan Ramaswamy
Annals of Clinical
Psychiatry, Volume 20, Issue 1 February 2008, pages 21 - 31
GRATIS 3 - Update on the Etiology and
Treatment of Schizophrenia and Bipolar Disorder
Peter F. Buckley
CNS Spectr.
2008;13(2 Suppl 1):1-12
GRATIS 3 - Appetite Regulation: Hormones and Antipsychotics
Donald S.
Robinson
Primary
Psychiatry. 2007;15(2):24-26
GRATIS 3! - Questioning an Axiom: Better
Prognosis for Schizophrenia in the Developing World?
Alex
Cohen, Vikram Patel, R. Thara
and Oye Gureje
Schizophrenia
Bulletin 2008 34(2):229-244
3 - Randomized Controlled Trials
for Schizophrenia: Study Designs Targeted to Distinct Goals
T.
Scott Stroup and John R. Geddes
Schizophrenia
Bulletin 2008 34(2):266-274
3 - The Association of Dropout
and Outcome in Trials of Antipsychotic Medication and Its Implications for
Dealing With Missing Data
Jonathan
Rabinowitz and Ori Davidov
Schizophrenia
Bulletin 2008 34(2):286-291
3 - The Phenomenological Critique
and Self-disturbance: Implications for Ultra-High Risk ("Prodrome") Research
Barnaby
Nelson, Alison R. Yung, Andreas Bechdolf and Patrick
D. McGorry
Schizophrenia
Bulletin 2008 34(2):381-392
| Regresar a RESÚMENES FEBRERO 2008 |